LP ‐925219 maximizes urinary glucose excretion in mice by inhibiting both renal SGLT 1 and SGLT 2
作者： David R. Powell , Melinda G. Smith , Deon D. Doree , Angela L. Harris , Wendy W. Xiong
DOI: 10.1002/PRP2.129
关键词:
摘要: … These studies demonstrate that oral delivery of LP-925219 can maximize UGE by inhibiting both renal SGLT1 and SGLT2. This conclusion was based on the use of 24-h UGE values …
sci-hub.se 参考文章(26)
Ele Ferrannini, Elza Muscelli, Silvia Frascerra, Simona Baldi, Andrea Mari, Tim Heise, Uli C. Broedl, Hans-Juergen Woerle, Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients Journal of Clinical Investigation. ,vol. 124, pp. 499- 508 ,(2014) , 10.1172/JCI72227
René Santer, Joaquim Calado, Familial Renal Glucosuria and SGLT2: From a Mendelian Trait to a Therapeutic Target Clinical Journal of The American Society of Nephrology. ,vol. 5, pp. 133- 141 ,(2010) , 10.2215/CJN.04010609
Timo Rieg, Takahiro Masuda, Maria Gerasimova, Eric Mayoux, Kenneth Platt, David R. Powell, Scott C. Thomson, Hermann Koepsell, Volker Vallon, Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia American Journal of Physiology-renal Physiology. ,vol. 306, ,(2014) , 10.1152/AJPRENAL.00518.2013
Aurora Merovci, Carolina Solis-Herrera, Giuseppe Daniele, Roy Eldor, Teresa Vanessa Fiorentino, Devjit Tripathy, Juan Xiong, Zandra Perez, Luke Norton, Muhammad A. Abdul-Ghani, Ralph A. DeFronzo, Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production Journal of Clinical Investigation. ,vol. 124, pp. 509- 514 ,(2014) , 10.1172/JCI70704
Chiara Ghezzi, Bruce A. Hirayama, Edurne Gorraitz, Donald D. F. Loo, Yin Liang, Ernest M. Wright, SGLT2 inhibitors act from the extracellular surface of the cell membrane Physiological Reports. ,vol. 2, ,(2014) , 10.14814/PHY2.12058
Giovanni Musso, Roberto Gambino, Maurizio Cassader, Gianfranco Pagano, A novel approach to control hyperglycemia in type 2 diabetes: Sodium glucose co-transport (SGLT) inhibitors. Systematic review and meta-analysis of randomized trials Annals of Medicine. ,vol. 44, pp. 375- 393 ,(2012) , 10.3109/07853890.2011.560181
V Levy, DC Swinney, J Breitkreutz, Drug Approval Times and User Fees: An International Perspective in a Changing World / Lexchin Number Needed to Detect: Nuances in the Use of a Simple and Intuitive Signal Detection Metric M Hauben, U Vogel, F Maignen Applications of Binding Kinetics to Drug Discovery: Translation of Binding Mechanisms to Clinically Differentiated Therapeutic Responses ,(2008)
B S Oemar, J Brodehl, D J Byrd, Complete absence of tubular glucose reabsorption: a new type of renal glucosuria (type 0). Clinical Nephrology. ,vol. 27, pp. 156- 160 ,(1987)
David C Swinney, The role of binding kinetics in therapeutically useful drug action. Current Opinion in Drug Discovery & Development. ,vol. 12, pp. 31- 39 ,(2009)
David C. Swinney, Applications of Binding Kinetics to Drug Discovery Pharmaceutical medicine. ,vol. 22, pp. 23- 34 ,(2008) , 10.1007/BF03256679